GHK-Cu and skin claims: what the evidence supports

A recent TikTok video from Ceia Clinic makes a broad claim: peptides, when used correctly, play a powerful role in skin rejuvenation and overall cellular support. The clip emphasizes that quality, formulation, and clinical guidance matter, and it announces the clinic's peptide offerings. While the message is not wrong in principle, it compresses a complex research landscape into a 15-second soundbite. This article unpacks what the research actually covers, where the gaps are, and how specific catalog peptides map to the claims.

What the clip is claiming

The video implies that peptides are a versatile tool for skin health and cellular function, and that clinical oversight ensures safety and efficacy. It also hints that not all peptides are equal, which is a fair point—but it does not specify which peptides, what evidence supports them, or what “used correctly” means. The viewer is left with a general impression that peptides are beneficial, without nuance about mechanisms, limitations, or the difference between cosmetic and research applications.

What the research neighborhood actually covers

Peptides are short chains of amino acids that act as signaling molecules. In the context of skin, the most studied peptide is GHK-Cu (copper tripeptide-1). Research, largely in vitro and in small human studies, suggests GHK-Cu can support collagen production, wound healing, and antioxidant activity. It is often included in topical skincare formulations. For “cellular support,” other peptides like NAD+ (a coenzyme, not a peptide, but often grouped in the peptide space) and MOTS-c (a mitochondrial-derived peptide) are investigated for metabolic and cellular health. However, the evidence for systemic anti-aging or “cellular support” in humans is far less robust than for topical GHK-Cu.

Limits, missing context, and what a 15-second clip cannot show

A short video cannot convey critical details: peptide stability, formulation (e.g., topical vs. injectable), dosing, and the difference between research-use and clinical use. For instance, GHK-Cu is available as a research chemical, but its cosmetic use is typically topical, not injectable. The clip also omits that many peptide claims are based on animal or cell studies, not large human trials. Furthermore, “quality and formulation” are not just about the source—they involve pH, buffers, storage, and delivery systems, which are rarely discussed in social media clips. Clinical guidance is essential, but it does not transform a research peptide into an approved therapeutic for all the implied benefits.

How this maps to catalog compounds

If the clip is about skin rejuvenation, the most relevant catalog compound is GHK-Cu. It is the only peptide in the catalog with a substantial body of evidence for skin-related applications. For broader “cellular support,” NAD+ and MOTS-c are sometimes cited, but their research is more about metabolism and aging, not direct skin effects. BPC-157 and TB-500 are often discussed for tissue repair, but they are not skin-specific. The clip’s generic language does not name any compound, so it is impossible to map it to a specific product. However, if a viewer assumes “peptides” means GHK-Cu, the evidence is mixed: topical GHK-Cu has supportive data, but injectable GHK-Cu for skin is not well-studied in humans.

Research-use caveat

All peptides listed in the catalog are for research use only (RUO). They are not approved for human consumption or clinical use. Researchers must handle them with appropriate protocols, including proper storage and reconstitution. The claims in the TikTok clip are promotional, not scientific, and should not be interpreted as evidence for any specific peptide’s efficacy or safety in humans. Always consult primary literature and follow institutional guidelines.